Bayer HealthCare and Nektar Therapeutics Collaborate

Bayer HealthCare AG and Nektar Therapeutics have announced a new collaboration to develop an inhaleable powder formulation of a novel form of Ciprofloxacin (Cipro) to treat chronic lung infections caused by Pseudomonas aeruginosa (P. aeruginosa) in cystic fibrosis patients.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18793220)